Inovio Pharmaceuticals
INO
#9739
Rank
$0.10 B
Marketcap
$0.99
Share price
-4.80%
Change (1 day)
-57.87%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of June 2026 : $8 Million USD

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is $8 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$9.36 M-21.05%
2024-12-31$11.86 M-60.72%
2023-12-31$30.2 M-5.82%
2022-12-31$32.07 M-2.87%
2021-12-31$33.02 M-15.43%
2020-12-31$39.04 M-60.76%
2019-12-31$99.5 M
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31$12.11 M0.04%
2008-12-31$12.1 M
2003-12-31$0.33 M1504.32%
2002-12-31$0.02 M-57.1%
2001-12-31$0.04 M
2001-03-31$0.11 M-0.78%
2000-03-31$0.11 M18.38%
1999-03-31$0.1 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
$49.03 B 612,697.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$49.01 B 612,422.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$63.19 B 789,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$26.24 B 327,893.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$53.90 B 673,557.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$24.16 B 301,906.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
$0.98 B 12,193.10%๐Ÿ‡บ๐Ÿ‡ธ USA